CREBBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.790100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.188400E-01
Normal-vs-Stage2
6.086500E-02
Normal-vs-Stage3
1.668360E-01
Normal-vs-Stage4
6.950200E-01
Stage1-vs-Stage2
8.548600E-01
Stage1-vs-Stage3
1.369930E-02
Stage1-vs-Stage4
4.045600E-01
Stage2-vs-Stage3
3.742400E-02
Stage2-vs-Stage4
2.170200E-01
Stage3-vs-Stage4
9.277700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.156100E-02
Normal-vs-AfricanAmerican
5.526600E-01
Normal-vs-Asian
1.021800E-01
Caucasian-vs-AfricanAmerican
1.319980E-01
Caucasian-vs-Asian
3.609600E-01
AfricanAmerican-vs-Asian
1.363040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.408300E-02
Normal-vs-Female
3.372800E-01
Male-vs-Female
2.437800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.598800E-01
Normal-vs-Age(41-60Yrs)
1.337650E-01
Normal-vs-Age(61-80Yrs)
3.903600E-02
Normal-vs-Age(81-100Yrs)
2.971000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.437000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.667400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.658640E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.506300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.247420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.751200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.711700E-02
Normal-vs-Daily Drinker
4.626300E-02
Normal-vs-Weekly Drinker
9.768500E-02
Normal-vs-Occasional Drinker
1.946960E-01
Normal-vs-Social Drinker
1.014030E-01
Non Drinker-vs-Daily Drinker
9.066600E-01
Non Drinker-vs-Weekly Drinker
9.991200E-01
Non Drinker-vs-Occasional Drinker
4.718000E-01
Non Drinker-vs-Social Drinker
4.816400E-01
Daily Drinker-vs-Weekly Drinker
9.185000E-01
Daily Drinker-vs-Occasional Drinker
4.016800E-01
Daily Drinker-vs-Social Drinker
3.750400E-01
Weekly Drinker-vs-Occasional Drinker
5.378800E-01
Weekly Drinker-vs-Social Drinker
5.059400E-01
Occasional Drinker-vs-Social Drinker
9.614600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.578300E-02
Normal-vs-Grade 2
2.129600E-02
Normal-vs-Grade 3
5.120700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.523800E-01
Grade 1-vs-Grade 3
1.029240E-01
Grade 1-vs-Grade 4
7.578300E-02
Grade 2-vs-Grade 3
5.001600E-01
Grade 2-vs-Grade 4
2.129600E-02
Grade 3-vs-Grade 4
5.120700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.520000E-02
Normal-vs-NonDiabetic
3.735700E-02
Diabetic-vs-NonDiabetic
9.397800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.551000E-01
Normal-vs-NoPancreatitis
4.778200E-02
Pancreatitis-vs-NoPancreatitis
9.657800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.017900E-02
Normal-vs-N1
7.332200E-02
N0-vs-N1
1.410850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.418020E-01
Normal-vs-TP53-NonMutant
2.149600E-01
TP53-Mutant-vs-TP53-NonMutant
7.184000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
